Erasca (ERAS) Treasury Shares (2020 - 2022)

Erasca (ERAS) reported Treasury Shares of $38810.0 for Q2 2022, down 89.93% on a YoY basis from $385337.0 in Q2 2021, and down 67.6% quarter-over-quarter from $119798.0 in Q1 2022.

Erasca (ERAS) Treasury Shares (2020 - 2022) Analysis & Trends

Erasca has reported Treasury Shares for 3 years, with the latest figure at $38810.0 in Q2 2022.

  • For the quarter ending Q2 2022, Treasury Shares fell 89.93% year-over-year to $38810.0; the trailing twelve-month figure through Jun 2022 stood at $38810.0 (down 89.93% YoY), and the FY2021 full-year result was $212941.0, down 61.82% from the prior year.
  • Treasury Shares for Q2 2022 stood at $38810.0, down from $119798.0 in the prior quarter.
  • The five-year high for Treasury Shares was $557731.0 in Q4 2020, with the low at $38810.0 in Q2 2022.
  • Historically, Treasury Shares has averaged $268959.3 across 3 years, with a median of $256040.0 in 2021.
  • Annual changes were most pronounced in 2021 — Treasury Shares slumped 61.82% — and 2022, when it sank 89.93%.
  • Erasca's Treasury Shares stood at $557731.0 in 2020, then tumbled by 61.82% to $212941.0 in 2021, then slumped by 81.77% to $38810.0 in 2022.
  • The last three Treasury Shares figures came in at $38810.0 (Q2 2022), $119798.0 (Q1 2022), and $212941.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 700,000.00
9 Abivax 91.96 Bn 91.96 Bn - -
10 Erasca 4.16 Bn 3.92 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 38,810.00
Jun 30, 2022 38,810.00
Mar 31, 2022 119,798.00
Mar 31, 2022 119,798.00
Dec 31, 2021 212,941.00
Dec 31, 2021 212,941.00
Sep 30, 2021 299,139.00
Sep 30, 2021 299,139.00
Jun 30, 2021 385,337.00
Jun 30, 2021 385,337.00
Dec 31, 2020 557,731.00
Dec 31, 2020 557,731.00